Sentiment-Signal
16,3
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 23.12.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | to Section 13(a) of the Exchange Act. o Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Ap |
| 21.05.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | to Section 13(a) of the Exchange Act. o Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Ap |
| 12.11.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | this Current Report on Form 8-K as Exhibit 99.1. Item 5.02. Departure of Directors or Certain Officers; Election of Dire |
| 05.05.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Of |
Stammdaten
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Unternehmen & Branche
| Name | Ginkgo Bioworks Holdings, Inc. |
|---|---|
| Ticker | DNA |
| CIK | 0001830214 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2836 · Biological Products, (No Diagnostic Substances) |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 454,2 Mio. USD |
| Beta | 1,57 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 170,155,000 | -312,763,000 | -5.64 | 1,119,696,000 | 508,590,000 |
| 2025-09-30 | 10-Q | 38,837,000 | -80,755,000 | -1.45 | 1,189,165,000 | 559,783,000 |
| 2025-06-30 | 10-Q | 49,604,000 | -1.10 | 1,231,009,000 | 612,952,000 | |
| 2025-03-31 | 10-Q | 48,318,000 | -1.68 | 1,293,463,000 | ||
| 2024-12-31 | 10-K | 227,043,000 | -547,029,000 | -10.54 | 1,377,449,000 | 716,058,000 |
| 2024-09-30 | 10-Q | 89,046,000 | -56,403,000 | -1.08 | 1,480,883,000 | 797,943,000 |
| 2024-06-30 | 10-Q | 56,206,000 | -217,181,000 | -4.23 | 1,625,255,000 | 833,072,000 |
| 2024-03-31 | 10-Q | 37,944,000 | -3.32 | 1,581,761,000 | ||
| 2023-12-31 | 10-K | 251,455,000 | -892,869,000 | -18.37 | 1,665,342,000 | 1,097,152,000 |
| 2023-09-30 | 10-Q | 55,430,000 | -302,891,000 | -6.21 | 2,026,392,000 | |
| 2023-06-30 | 10-Q | 80,568,000 | -173,315,000 | -0.09 | 2,291,999,000 | |
| 2023-03-31 | 10-Q | 80,702,000 | -204,969,000 | -0.11 | 2,417,209,000 | |
| 2022-12-31 | 10-K | 477,706,000 | -2,104,929,000 | -50.20 | 2,539,321,000 | 1,736,277,000 |
| 2022-09-30 | 10-Q | 66,398,000 | -670,131,000 | -0.41 | 1,870,695,000 | 1,434,736,000 |
| 2022-06-30 | 10-Q | 144,618,000 | -668,825,000 | -0.41 | 1,994,219,000 | 1,535,431,000 |
| 2022-03-31 | 10-Q | 168,405,000 | -590,505,000 | -0.37 | 2,057,726,000 | 1,580,795,000 |
| 2021-12-31 | 10-K | 313,837,000 | -1,830,047,000 | -1.39 | 2,070,990,000 | 1,505,365,000 |
| 2021-09-30 | 10-Q | 77,610,000 | -101,881,000 | -0.08 | 2,150,591,000 | 1,551,551,000 |
| 2021-06-30 | 10-Q | 43,636,000 | -53,941,000 | -0.04 | 1,725,987,976 | 5,000,009 |
| 2021-03-31 | 10-Q | 44,097,000 | -73,569,000 | 1,728,030,671 | 5,000,004 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-17 | Coen Steven P. | Officer, See remarks | Open Market Sale | -324 | 7.95 | -2,576.45 | -1,4% | |
| 2026-04-13 | Coen Steven P. | Officer, See remarks | Open Market Sale | -33,171 | 6.41 | -212,758.79 | -114,3% | |
| 2026-04-10 | Shetty Reshma P. | Director, Officer, 10% Owner, See remarks | Open Market Sale | -124,727 | 6.43 | -802,493.52 | -431,1% | |
| 2026-04-10 | Canton Barry | 10% Owner | Open Market Sale | -124,727 | 6.43 | -802,493.52 | -431,1% | |
| 2026-04-09 | Canton Barry | 10% Owner | Open Market Sale | -13,116 | 6.40 | -83,903.05 | -45,1% | |
| 2026-04-09 | Kelly Jason R | Director, Officer, See remarks | Open Market Sale | -109,767 | 6.40 | -702,179.50 | -377,2% | |
| 2026-04-09 | Shetty Reshma P. | Director, Officer, 10% Owner, See remarks | Open Market Sale | -13,116 | 6.40 | -83,903.05 | -45,1% | |
| 2026-04-08 | Canton Barry | 10% Owner | Open Market Sale | -13,155 | 6.93 | -91,164.15 | -49,0% | |
| 2026-04-08 | Shetty Reshma P. | Director, Officer, 10% Owner, See remarks | Open Market Sale | -13,155 | 6.93 | -91,164.15 | -49,0% | |
| 2026-04-08 | Kelly Jason R | Director, Officer, See remarks | Open Market Sale | -97,015 | 6.93 | -672,313.95 | -361,2% | |
| 2026-03-16 | Coen Steven P. | Officer, See remarks | Open Market Sale | -708 | 6.74 | -4,768.38 | -2,6% | |
| 2026-01-20 | Coen Steven P. | Officer, See remarks | Open Market Sale | -972 | 8.92 | -8,667.32 | -4,7% | |
| 2025-12-15 | Coen Steven P. | Officer, See remarks | Open Market Sale | -736 | 8.89 | -6,540.10 | -3,5% | |
| 2025-10-17 | Coen Steven P. | Officer, See remarks | Open Market Sale | -1,312 | 13.65 | -17,907.49 | -9,6% | |
| 2025-10-01 | Coen Steven P. | Officer, See remarks | Open Market Sale | -5,609 | 15.00 | -84,135.00 | -45,2% | |
| 2025-09-09 | HENRY CHRISTIAN O | Director | Open Market Sale | -10,000 | 11.06 | -110,600.00 | -59,4% | |
| 2025-09-08 | HENRY CHRISTIAN O | Director | Open Market Sale | -10,000 | 10.92 | -109,200.00 | -58,7% | |
| 2025-08-22 | Coen Steven P. | Officer, See remarks | Open Market Sale | -310 | 12.40 | -3,842.76 | -2,1% | |
| 2025-07-17 | Coen Steven P. | Officer, See remarks | Open Market Sale | -1,084 | 9.84 | -10,668.73 | -5,7% | |
| 2025-05-21 | Dmytruk Mark E. | Officer, See remarks | Open Market Sale | -706 | 7.59 | -5,355.01 | -2,9% | |
| 2025-05-21 | Coen Steven P. | Officer, See remarks | Open Market Sale | -346 | 7.59 | -2,624.41 | -1,4% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.